Centrose

Centrose is a biotechnology company specializing in the development of Extracellular Drug Conjugates (EDCs) for the treatment of cancer and other serious diseases. Based in Madison, Wisconsin, the company utilizes its proprietary EDC platform to create therapies that target the Na+/K+-ATPase pump on the cell surface. Unlike traditional antibody-drug conjugates that must be internalized to be effective, Centrose's EDCs work by binding to specific ion pump isoforms, triggering a rapid and targeted therapeutic response. This approach is designed to enhance efficacy while minimizing the off-target effects typically associated with systemic treatments. The company's pipeline includes several pre-clinical candidates focused on oncology indications with high unmet medical needs.